by Mark Curtis | Nov 19, 2013
. Welcome to October’s Update from the Clinic. Interesting developments this past month included the release of Phase 1/2a data from Living Cell Technologies that provides a first look at the safety and efficacy of its DIABECELL® product. We also saw an approval for...
by Mark Curtis | Oct 17, 2013
. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...
by Stacey Johnson | Oct 4, 2013
. With over 1,000 TED Talks, it’s inevitable that more than one good regenerative medicine talk will appear in Right Turn. The talk below, by Dr. Robert Langer of MIT, takes some commitment at nearly 18 minutes in running time, but if you’re a fan of biomaterials (or...
by Mark Curtis | Oct 3, 2013
. I have recently joined the business development group at CCRM, as an analyst, and believe it would be useful to start compiling some recaps on clinical developments in the regenerative medicine (RM) and cell therapy industries to complement the other science-related...
by Stacey Johnson | Sep 20, 2013
. You have no doubt heard and read a lot about 3D printing. Biomaterials scientist and blogger Patrick Blit has written about it here in the context of a 3D printed tracheal splint. It is an increasingly popular method for creating human tissues and has evolved to...
by Sasha (Alexandra) Lisovsky | Sep 5, 2013
. I recently spent a week in a rustic New England area hiking, canoeing, tasting local beer, sampling culinary masterpieces and participating in insightful discussions with old and newly acquired friends. It sounds like I had a great vacation; however, I was actually...
Comments